World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
42
Citations
7363
World Ranking
4887
National Ranking
408

Martin O. C. Ota publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Martin O. C. Ota sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 92 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Martin O. C. Ota D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin O. C. Ota sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 42 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Martin O. C. Ota is affiliated with GlaxoSmithKline in Belgium, with research focusing primarily on medical sciences. The scientist's work spans several key areas within the broader field of Medicine, including subfields such as Infectious Diseases, Epidemiology, and Surgery.

Ota's research emphasizes Tuberculosis Research and Epidemiology, with a notable concentration on Mycobacterium research and diagnosis, as well as Infectious Diseases and Tuberculosis. These topics reflect a targeted interest in understanding and diagnosing infectious diseases, particularly tuberculosis.

The scientist has contributed scholarly articles to specialized venues, most notably publishing in the journal Tuberculosis. Among recent papers, one titled "Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis" was published in 2022.

  • Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis, 2022, Tuberculosis

Collaborative efforts are a consistent aspect of Ota's work, including multiple authorships with several frequent co-authors. Key collaborators include:

  • Kim Stanley
  • Stephanus T. Malherbe
  • Gerhard Walzl
  • Novel N. Chegou
  • Ruschca Jacobs

The concentration of research in infectious diseases and tuberculosis aligns with Ota's primary publication venues and subfields of study.

Best Publications

  • A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

    Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson

  • Newborns Develop a Th1-Type Immune Response to Mycobacterium bovis Bacillus Calmette-Guérin Vaccination

    Arnaud Marchant;Tessa Goetghebuer;Martin O. Ota;Ingrid Wolfe

  • Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination

    Martin O. C. Ota;Johan Vekemans;Susanna E. Schlegel-Haueter;Katherine Fielding

  • Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis

    Sara Suliman;Ethan G. Thompson;Jayne Sutherland;January Weiner rd

  • Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease.

    Jayne S. Sutherland;Ifedayo M. Adetifa;Philip C. Hill;Richard A. Adegbola

  • Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes.

    Johan Vekemans;Johan Vekemans;Amedeo Amedei;Martin O. Ota;Mario M. D'Elios

  • Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia.

    Diarmuid O'donovan;Koya Ariyoshi;Paul Milligan;Martin Ota

  • Functional Correlations of Pathogenesis-Driven Gene Expression Signatures in Tuberculosis

    Jeroen Maertzdorf;Martin Ota;Dirk Repsilber;Hans J. Mollenkopf

  • Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

    Gillian F. Black;Bonnie A. Thiel;Martin O. Ota;Shreemanta K. Parida

  • Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.

    Birahim Pierre Ndiaye;Friedrich Thienemann;Martin Ota;Bernard S Landry

  • The Influence of Placental Malaria Infection and Maternal Hypergammaglobulinemia on Transplacental Transfer of Antibodies and IgG Subclasses in a Rural West African Population

    Brown J. Okoko;Lalanga H. Wesumperuma;Martin O. C. Ota;Margaret Pinder

  • Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults.

    Martin O C Ota;Johan Vekemans;Susanna E Schlegel-Haueter;Katherine Fielding

  • Vaccine confidence: the keys to restoring trust.

    Selim Badur;Martin O. C. Ota;Serdar Öztürk;Richard Adegbola

  • Production of TNF-α, IL-12(p40) and IL-17 Can Discriminate between Active TB Disease and Latent Infection in a West African Cohort

    Jayne S. Sutherland;Bouke C. de Jong;David J. Jeffries;Ifedayo M. Adetifa

  • The epidemiology and consequences of maternal malaria: a review of immunological basis

    Brown J. Okoko;G. Enwere;M.O.C. Ota

  • Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay

    S. A. Joosten;J. J. Goeman;J. S. Sutherland;L. Opmeer

  • Impact of COVID-19 pandemic on routine immunization.

    Martin O C Ota;Selim Badur;Luis Romano-Mazzotti;Leonard R Friedland

  • T cell responses to vaccines in infants: defective IFNγ production after oral polio vaccination

    J Vekemans;M O Ota;E C Y Wang;Michael Kidd

  • Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age

    Sarah Burl;Uche J. Adetifa;Momodou Cox;Ebrima Touray

  • Polyfunctional CD4+ and CD8+ T Cell Responses to Tuberculosis Antigens in HIV-1–Infected Patients before and after Anti-Retroviral Treatment

    Jayne S. Sutherland;James M. Young;Kevin L. Peterson;Bakary Sanneh

  • Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population.

    Brown J. Okoko;Lalanga H. Wesuperuma;Martin O.C. Ota;Winston A.S. Banya

Frequent Co-Authors

Richard A. Adegbola
Richard A. Adegbola Nigerian Institute of Medical Research
Martin Antonio
Martin Antonio London School of Hygiene & Tropical Medicine
Arnaud Marchant
Arnaud Marchant Université Libre de Bruxelles
Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
Beate Kampmann
Beate Kampmann Charité - University Medicine Berlin
Keith P. W. J. McAdam
Keith P. W. J. McAdam London School of Hygiene & Tropical Medicine
Hilton Whittle
Hilton Whittle London School of Hygiene & Tropical Medicine
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann Max Planck Institute for Infection Biology
Gerhard Walzl
Gerhard Walzl Stellenbosch University
Melanie J. Newport
Melanie J. Newport Brighton and Sussex Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which can be advanced through specialized nursing programs. For those looking to transition quickly, accelerated nursing programs offer a fast track to becoming a registered nurse, building a strong foundation in patient care and immunological applications.

Entry-level healthcare roles such as Licensed Practical Nurse (LPN) positions are accessible through accredited LPN programs easy to get into. These programs focus on practical skills and can complement immunology knowledge in clinical settings.

For advanced practice nurses, pursuing an easiest nurse practitioner program can expand career opportunities in immunology-related specialties. These programs equip students with expertise in diagnosis and treatment.

Furthermore, specialized fields such as mental health benefit from targeted education paths like the top psychiatric mental health nurse practitioner programs online. These programs offer strong clinical placements, essential for managing immune-related psychiatric conditions.

Best Scientists Citing Martin O. C. Ota

Trending Scientists

Recently Published Articles